- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Genomic Health Inc
+ Add to WatchlistGHDX:US
37.2100 USD 0.0400 0.11%As of 20:10:00 ET on 05/20/2013.
Snapshot for Genomic Health Inc (GHDX)
| Open: | 37.4400 | Day's Range: | 36.7000 - 37.4700 | Volume: | 398,708 |
|---|---|---|---|---|---|
| Previous Close: | 37.2500 | 52wk Range: | 25.2500 - 37.4700 | 1-Yr Rtn: | +17.57% |
Key Statistics for GHDX
| Current P/E Ratio (ttm) | 186.0500 |
|---|---|
| Estimated P/E(12/2013) | 198.9840 |
| Relative P/E vs. SPX | 11.4022 |
| Earnings Per Share (USD) (ttm) | 0.2000 |
| Est. EPS (USD) (12/2013) | 0.1870 |
| Est. PEG Ratio | 8.0560 |
| Market Cap (M USD) | 1,124.39 |
| Shares Outstanding (M) | 30.22 |
| 30 Day Average Volume | 245,397 |
| Price/Book (mrq) | 8.6108 |
| Price/Sale (ttm) | 4.7121 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GHDX
Company Profile & Key Executives for GHDX
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.
| Kimberly J Popovits "Kim"Chairman/President/CEO | Dean L SchornoChief Financial Officer |
| G Bradley ColeChief Operating Officer | Steven ShakExec VP:Research & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GHDX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page